Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hill & Smith PLC Director's Dealing 2026

May 27, 2026

4647_dirs_2026-05-27_2506bbf3-d4f7-4376-b026-f5214e54ef58.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9325F

Hill & Smith PLC

27 May 2026

Hill & Smith PLC

(the 'Company' or 'Hill & Smith')

Director / PDMR Shareholding

Hill & Smith announces that on 26 May 2026, it was notified of the exercise and subsequent sale by Chris McLeish, Chief Financial Officer of Shares under his 2023 Deferred Bonus Buy-Out Award.

The Notification of Dealing Form can be found below:

1. Details of the person discharging managerial responsibilities/person closely associated
(a) Name Chris McLeish
2. Reason for the notification
(a) Position/status Chief Financial Officer
(b) Initial notification/ Amendment Initial notification
3. Details of the issuer
(a) Name Hill & Smith PLC
(b) LEI 2138003A3ISGQZBOWI83
4.1 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a) Description of the Financial Instrument Ordinary Shares of £0.25 each
(b) Identification code of the Financial Instrument GB0004270301
(c) Nature of the transaction Acquisition of Ordinary Shares pursuant to the exercise of an award under his 2023 Deferred Bonus Buy-Out Award.
(d) Price(s) and volume(s) Price(s) Volume(s)
Nil 5,690
(e) Aggregated information N/A
- Aggregated volume
- Price
(f) Date of the transaction 26 May 2026
(g) Place of the transaction Outside of a trading venue
4.2 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a) Description of the Financial Instrument Ordinary Shares of £0.25 each
(b) Identification code of the Financial Instrument GB0004270301
(c) Nature of the transaction Sale of Ordinary Shares to cover tax and NI liability on the exercise of awards outlined in 4.1.
(d) Price(s) and volume(s) Price(s) Volume(s)
£27.60 2,682
(e) Aggregated information N/A
- Aggregated volume
- Price
(f) Date of the transaction 26 May 2026
(g) Place of the transaction XLON

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHAKOBKQBKDKPB